METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS
The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., rheumatoid arthritis (RA) patients, e.g., high risk RA patients, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragme...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MPOFU, Shepard THANGAVELU, Karthinathan MACHACEK, Matthias RICHARDS, Hanno |
| description | The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., rheumatoid arthritis (RA) patients, e.g., high risk RA patients, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3757126A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3757126A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3757126A13</originalsourceid><addsrcrecordid>eNrjZLD3dQ3x8HcJVvB3UwgJcnUM8fRzVwgI9g_yBDKdFRyDQjyCPEM8gxVCg0Eynj66huYKjn4hju7-fp7BIcE8DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSTeNcDY3NTc0MjM0dCYCCUAOr0qFg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS</title><source>esp@cenet</source><creator>MPOFU, Shepard ; THANGAVELU, Karthinathan ; MACHACEK, Matthias ; RICHARDS, Hanno</creator><creatorcontrib>MPOFU, Shepard ; THANGAVELU, Karthinathan ; MACHACEK, Matthias ; RICHARDS, Hanno</creatorcontrib><description>The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., rheumatoid arthritis (RA) patients, e.g., high risk RA patients, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof).</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201230&DB=EPODOC&CC=EP&NR=3757126A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201230&DB=EPODOC&CC=EP&NR=3757126A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MPOFU, Shepard</creatorcontrib><creatorcontrib>THANGAVELU, Karthinathan</creatorcontrib><creatorcontrib>MACHACEK, Matthias</creatorcontrib><creatorcontrib>RICHARDS, Hanno</creatorcontrib><title>METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS</title><description>The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., rheumatoid arthritis (RA) patients, e.g., high risk RA patients, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof).</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD3dQ3x8HcJVvB3UwgJcnUM8fRzVwgI9g_yBDKdFRyDQjyCPEM8gxVCg0Eynj66huYKjn4hju7-fp7BIcE8DKxpiTnFqbxQmptBwc01xNlDN7UgPz61uCAxOTUvtSTeNcDY3NTc0MjM0dCYCCUAOr0qFg</recordid><startdate>20201230</startdate><enddate>20201230</enddate><creator>MPOFU, Shepard</creator><creator>THANGAVELU, Karthinathan</creator><creator>MACHACEK, Matthias</creator><creator>RICHARDS, Hanno</creator><scope>EVB</scope></search><sort><creationdate>20201230</creationdate><title>METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS</title><author>MPOFU, Shepard ; THANGAVELU, Karthinathan ; MACHACEK, Matthias ; RICHARDS, Hanno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3757126A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MPOFU, Shepard</creatorcontrib><creatorcontrib>THANGAVELU, Karthinathan</creatorcontrib><creatorcontrib>MACHACEK, Matthias</creatorcontrib><creatorcontrib>RICHARDS, Hanno</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MPOFU, Shepard</au><au>THANGAVELU, Karthinathan</au><au>MACHACEK, Matthias</au><au>RICHARDS, Hanno</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS</title><date>2020-12-30</date><risdate>2020</risdate><abstract>The disclosure relates to novel regimens for treating an inflammatory arthritis, e.g., rheumatoid arthritis (RA) patients, e.g., high risk RA patients, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., IL-17 binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof, e.g., secukinumab) or IL-17 receptor binding molecule (e.g., IL-17 antibody or antigen binding fragment thereof).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3757126A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A55%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MPOFU,%20Shepard&rft.date=2020-12-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3757126A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |